BioLife Solutions, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate
BioLife Solutions, Inc. (BLFS) reported Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate of 105.20% for the 3-month period ending 2013-09-30, per its 10-Q filed 2013-11-14.
Discontinued › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate · last filed 2013-11-14
- BioLife Solutions, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate for the quarter ending 2013-09-30 was 105.20%, a 3.57% increase year-over-year.
- BioLife Solutions, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate for the quarter ending 2012-09-30 was 101.57%, a 9.98% increase year-over-year.
- BioLife Solutions, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate for the quarter ending 2012-06-30 was 104.95%.
- BioLife Solutions, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate for the quarter ending 2012-03-31 was 101.00%.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate 9 month |
|---|---|---|---|
| 2013-09-30 | 105.20% 10-Q · filed 2013-11-14 | 105.20% 10-Q · filed 2013-11-14 | |
| 2012-09-30 | 101.57% 10-Q · filed 2013-11-14 | 102.76% 10-Q · filed 2013-11-14 | |
| 2012-06-30 | 104.95% 10-Q · filed 2013-08-12 | 103.12% 10-Q · filed 2013-08-12 | |
| 2012-03-31 | 101.00% 10-Q · filed 2013-05-14 | ||
| 2011-09-30 | 92.35% 10-Q · filed 2012-11-13 | 92.72% 10-Q · filed 2012-11-13 | |
| 2011-06-30 | 0.00% 10-Q · filed 2012-08-14 | 93.00% 10-Q · filed 2012-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| TransMedics Group, Inc. (TMDX) | United States | $2.911B | 15.17 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| electroCore, Inc. (ECOR) | United States | $0.102B |